Radiology of COVID-19 pneumonia by Said-Hartley, Qonita & Moosa, Sulaiman
276
BACKGROUND
Coronavirus disease (COVID-19) was declared when a cluster 
of pneumonia cases was reported in Wuhan, China, on 
31 December 2019. The causative agent, a novel coronavirus, 
was detected, and being similar to the SARS virus, was named 
SARS-CoV-2. The virus rapidly spread despite the attempted 
containment in the city, with over 7 000 cases reported in 
China and 82 cases (in 18 countries) outside of China by the 
end of January 2020, when the WHO declared a public health 
emergency.(1)
On 11 March 2020 the WHO declared COVID-19 a pandemic 
and South Africa had by that time recorded 13 cases, all of 
which had been imported. As of 17 June 2020, South Africa has 
recorded over 80 000 cases and more than 1 600 deaths.(2) 
COVID-19 is mainly a respiratory illness and lung imaging 
plays an important role. This was even more evident with 
the initial low sensitivity of Reverse Transcriptase-Polymerase 
Chain Reaction (RT-PCR) tests, in addition to the long turn-
around time to yield results. A large study of 1 014 patients in 
Wuhan showed that Computed Tomography (CT) had a 
higher sensitivity (98%) compared to a RT-PCR test (71%).(3) 
As more and more studies were performed, however, it 
became evident that CT had a low negative predictive value in 
the early stages of the disease and hence societies such as the 
Society of Thoracic Radiology and the American Society for 
Emergency Radiology recommended that routine CT screening 
should not be used for diagnosis.(4) Conversely, an abnormal 
chest CT is not specific for COVID-19 infection. 
Chest X-ray (CXR) and CT lung findings of COVID-19 infection 
have now been well described, and will be discussed and 
described in this pictorial review.
The following are commonly reported findings:
 ■ Ground glass opacity
 ■ Consolidation
 ■ Linear opacity
 ■ Crazy-paving
 ■ Reversed halo sign
GROUND GLASS OPACITY (GGO)
GGO is the most commonly reported finding on CXR and CT 
chest.(3) Abnormalities are more often described as bilateral 
than unilateral (except in early disease), peripheral more than 
central in location, but with increasing severity there is notably 
increased total lung involvement.(3)
Ground glass opacity (GGO) is defined by the Fleischner 
Society as a “hazy increased lung density with preservation of 
bronchial and vascular walls”.(5) CT is more sensitive for 
detecting GGO (Figure 2). On the CXR, GGO is seen as 
peripheral areas of increased density with loss of clarity of 
bronchovascular markings due to superimposition of structures 
(Figure 1). 





Coronavirus disease (COVID-19) started as a cluster of 
pneumonia cases in December 2019 and has rapidly 
spread across the world, resulting in millions of infec-
tions, and approaching one million deaths. In this short 
review we describe the most common chest x-ray and 
computed tomography manifestations of the virus as it 
affects the respiratory system, and make brief refer-
ences to the common clinical presentations. 
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GGO has a wide differential diagnosis, including infection (viral, 
fungal and less often bacterial), f luid overload, pulmonary 
haemorrhage and interstitial lung disease (including hyper-
sensitivity pneumonitis and collagen vascular disease). In the 
setting of HIV, infection due to Pneumocystis jerovicii 
pneumonia as well as drug toxicity should also be considered. 
CONSOLIDATION
Consolidation is defined as the process whereby fluid or cells 
replace the alveolar air to such an extent that the lung becomes 
solid.(5) Consolidation is associated with the air-bronchogram 
sign, which is due to air-filled bronchi being outlined by air-
less or densely opacified lung parenchyma. This sign can be 
seen on CXR and CT and is commonly associated with 
infectious (bacterial) pneumonia in the acute setting. In 
COVID-19 pneumonia, consolidation is multifocal, and is often 
segmental with mid to lower zone preponderance (Figure 3). 
As the disease progresses, consolidation becomes the more 
dominant pattern with increasing central lung involvement 
(Figures 4, 5).(6)
LINEAR OPACITY
Described as lines or band-like, linear opacities can be as a 
result of atelectasis or interstitial thickening (Figure 6). Linear 
opacities can be oriented horizontally, obliquely or parallel to 
the pleural surface and are often longer and thicker than 
interlobular septa (Figure 7). They can have an arc-shaped 
morphology in keeping with perilobular opacities, i.e. disease 
process at the periphery of the secondary lobule (Figure 8), 
which is well described in organising pneumonia.(5)
CRAZY-PAVING
Crazy-paving is the appearance of the lung when ground glass 
opacities are superimposed with reticular opacities, the latter in 
the form of interlobular septal and intra-lobular interstitial 
thickening.(5) This finding is commonly seen in other infections 
such as PCP, in pulmonary oedema, as well as in interstitial 
lung disease. As COVID-19 disease severity increases, crazy-
paving (Figure 9a + 9b) is more frequently seen along with 
FIGURE 1: Frontal CXR: Bilateral mid- to lower-zone ground 
glass opacity in a COVID-19 confirmed case.
FIGURE 2: Axial CT shows patchy and lobular GGO in a 
predominantly peripheral distribution in this confirmed 
COVID-19 patient. GGO can be seen extending into the upper 
lobes – especially notable on CT. Note the preservation of 
bronchovascular structures (bronchial wall and vessels can be 
seen through the lesions), typical for GGO.
FIGURE 3: Frontal CXR: Severe COVID-19 pneumonia in an 
intubated patient, showing extensive bilateral GGO and areas of 
consolidation in the mid- and lower zones.
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FIGURE 6: CXR of COVID-19 patient shows bilateral basal 
linear opacities with background GGO.
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consolidation and air-bronchogram and is associated with a 
poorer prognosis.(6)
REVERSED HALO (ATOLL) SIGN
The reversed halo sign is defined as a focal rounded area of 
ground glass opacification surrounded by a rim (complete or 
incomplete) of consolidation.(5) This has been likened to a 
coral reef or “atoll”, hence the name and it has been described 
in patients with organising pneumonia and now in COVID-19 
pneumonia. It typically develops during the later stages of 
the disease in areas with nodular opacities (Figure 10a) or 
consolidations.(7) In addition, a perilobular morphology has also 
been described in many patients with confirmed COVID-19 
pneumonia (Figure 10b), with arc-like linear opacities con-
forming to the periphery of the secondary pulmonary lobule.(7)
FIGURE 4: Axial CT of a patient with confirmed COVID-19 
pneumonia, demonstrating extensive bilateral peripheral and 
central mixed density opacification with areas of consolidation 
and air-bronchogram. Areas of sub-pleural sparing are denoted 
bilaterally (arrow).
FIGURE 5: Axial CT: Right upper lobe consolidation in a 
confirmed COVID-19 patient with pre-existing lymphoma 
(causing a large mediastinal mass and bilateral pleural effusions). 
An air-bronchogram sign is shown by the arrow.
FIGURE 7: Axial CT: Right mid to lower zone linear opacities 
(arrows) in a COVID-19 confirmed patient.
FIGURE 8: Axial CT: Bilateral linear opacities in a perilobular 














Less commonly reported findings are:
 ■ Discrete nodules with/without tree-in-bud




Discrete nodules are less commonly described, if at all reported 
in COVID-19 pneumonia (Figure 11). More often, disease 
detected in the early stage has been described as nodular, 
sometimes solitary, with subsequent development of bilateral 
multifocal more extensive changes.(8)
PLEURAL EFFUSIONS
Typically occurring in the later stage of the disease in a small 
number of patients, pleural effusions are a less typical finding in 
COVID-19 pneumonia. When present, pleural effusions have 
been associated with a poor prognosis.(6) The presence of a 
pleural effusion should raise suspicion for acute pulmonary 
embolism, as would be the case of non-COVID patients, and 
this diagnosis must always be considered when there is an 
acute clinical deterioration (Figure 12). Research has shown 
that earlier detection of pulmonary embolism may improve 
outcome with resultant earlier commencement of therapeutic 
dose anti-coagulation.(9) A significantly elevated D-dimer level 
FIGURE 9a and b: Axial CT. Figure 9a demonstrates patchy ground glass opacities superimposed with interstitial thickening, resulting in a 
crazy-paving pattern (arrows). Zoomed image (Figure 9b) of the right upper lobe with crazy-paving.
A B
FIGURE 10a and b: Reversed halos can be seen in these 2 patients with confirmed COVID-19 pneumonia (arrows). Areas of central low 




has also been associated with poor outcome.(9) In patients with 
myocardial involvement, pleural effusions are a sign of cardiac 
failure and fluid overload. Pre-existing pleural disease should 
also be considered (Figure 13) in immune-compromised 
patients, including infection and metastatic involvement. 
LYMPHADENOPATHY
Lymphadenopathy is a less common finding in COVID-19 
pneumonia patients (Figure 12) compared to non-COVID 
pneumonia.(7) In South Africa, a country with a high HIV 
prevalence of 20.4% amongst adults,(10) lymphadenopathy 
should raise suspicion of other pre-existing infectious aeti-
ologies such as mycobacterial infection and malignancy such 
as lymphoma. 
CAVITATION
Cavitation is described as (intralesional) areas of gas or lucency 
within airspace opacification.(5) This is an uncommon finding in 
COVID-19 infection, but has been described in an early case 
series.(11) We have not had any cases showing cavitation.
CONCLUSION
No CT finding is pathognomonic of SARS-CoV-2 infection. 
In fact, the commonest f inding in patients with confirmed 
COVID-19 pneumonia is GGO,(3) which is also the most 
commonly described finding in other viral pneumonias such 
as influenza and SARS amongst others. Clinical-radiological-
virological correlation is important, however, and in the pre-
sence of a pandemic this should be the most likely diagnosis in 
the radiological report.
In a confirmed COVID-19 pneumonia patient who has per-
sistent hypoxia, findings can include the signs associated with 
an organising pneumonia such as a perilobular pattern and 
the reversed halo sign. Early reports of significant clinical 
improvement following commencement of steroid treatment 
have been noted and imaging follow-up of these patients will 
be essential to evaluate for infection resolution as opposed to 
pulmonary fibrosis as a sequelae.
Pulmonary thrombo-embolism should be considered earlier 
rather than later during clinical deterioration,(12) and correlation 
with D-dimer levels with/without CT pulmonary angiography 
should be used to aid management.(9)
FIGURE 11: Axial CT: Nodular area of peripheral GGO 
evident in the right upper lobe of this COVID-19 confirmed 
case. Patchy less discrete opacity is seen more anteriorly in the 
right upper lobe.
FIGURE 13: Axial CT: Bilateral peripheral GGO with small 
pleural effusions in a patient diagnosed with leukaemia and post 
stem cell transplant.
FIGURE 12: Axial CT: COVID-19 confirmed patient com-
plicated by extensive bilateral pulmonary embolism, worse on 
the right (long arrow). Associated small left pleural effusion 













Lastly, in our HIV-endemic population, the presence of pre-
existing lung disease, especially pulmonary tuberculosis, is 
high. In patients with low CD4 counts (<200), Pneumocystis 
pneumonia must always be considered in the differential 
diagnosis of GGO and hypoxia. Chest radiographic inter-
pretation can be complicated and a low threshold for CT of 
the chest is recommended for more accurate evaluation and 
especially to exclude other conditions. 
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